Compare Globus Medical Inc. Class A Common Stock (GMED) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs J B Hunt Transport Services Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while J B Hunt Transport Services Inc trades at $230.52 (market cap $21.52B). The key difference: J B Hunt Transport Services Inc is far larger — about 2.1× Globus Medical Inc. Class A Common Stock's market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and J B Hunt Transport Services Inc for 46 Days on average.
| GMED | JBHT | |
|---|---|---|
Market Cap | $10.25B | $21.52B |
Volume | 1,108,124 | 994,790 |
Sector | Health | Industrials |
52-Week High | $96.82 | $298.41 |
52-Week Low | $58.33 | $138.83 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $9.76B | $22.66B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
JBHT trades at $232.16, up 1.69% today, with a bearish technical signal but strong fundamental profitability. Recent earnings have consistently beaten expectations, with Q3 2026 results due October 15, 2026. The company maintains solid margins, with a net income margin of 5.31% and ROE of 18.45%, though revenue has declined from 2022 peaks. Cash flow from operations remains healthy at $1.68 billion for 2025.
Analyst consensus is bullish with a $287.93 price target, but near-term risks include rising costs pressuring Q3 earnings and multiple law firm investigations into potential securities claims. The stock offers upside if execution improves, but investors face headwinds from fuel expenses and legal overhangs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
